← К результатам

Emerging applications of CRISPR/Cas9 gene editing technology in reversing drug resistance in oral squamous cell carcinoma.

Elumalai P, Ezhilarasan D

Oral oncology, 134: 106100 PMID 36063701 DOI 10.1016/j.oraloncology.2022.106100